DTIL: Precision BioSciences Inc

DTIL新闻

• 15:13 DTIL Revenue Drops 99%
• 13:25 Precision BioSciences (DTIL) Reports Q2 Loss, Lags Revenue Estimates
• 21:45 Immunome, Inc. (IMNM) Reports Q2 Loss, Beats Revenue Estimates
• 11:11 Precision BioSciences reports positive data for hepatitis B gene therapy
• 22:20 Qiagen (QGEN) Matches Q2 Earnings Estimates
• 14:15 The Play On TG Therapeutics (NASDAQ:TGTX)
• 12:10 Precision BioSciences stock rises after FDA grants orphan drug status
• 11:08 FDA grants orphan drug status to Precision BioSciences’ DMD treatment
• 16:10 Precision BioSciences gets FDA orphan drug designations for DMD treatment
• 11:15 Precision BioSciences reports promising DMD gene editing results
• 10:20 Precision Biosciences director Brown buys $6963 in DTIL stock
• 10:17 Precision Biosciences director Buehler buys $21k in shares
• 20:05 TG Therapeutics: Another Possible Avenue Of MS Growth With Azer-Cel (NASDAQ:TGTX)
• 11:17 FDA grants rare pediatric disease status to Precision BioSciences DMD therapy
• 11:13 Precision BioSciences stock jumps after FDA grants rare pediatric designation
• 11:19 precision biosciences reports voting outcomes at annual shareholder meeting
• 11:16 Precision BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update
• 08:44 CRISPR And Intellia: Balancing Market Uncertainty Against Pipeline Catalysts (NASDAQ:CRSP)
• 11:40 Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Aspira Womens Health (NASDAQ:AWH), Aclarion (NASDAQ:ACON)
• 12:42 Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-Cel (NASDAQ:DTIL)
• 19:27 Precision BioSciences Touts Encouraging Initial Safety And Antiviral Activity Of Hepatitis B Treatment Candidate - Precision BioSciences (NASDAQ:DTIL)